BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 4202631)

  • 1. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.
    Piessens WF; Schur PH; Moloney WC; Churchill WH
    N Engl J Med; 1973 Jan; 288(4):176-80. PubMed ID: 4629847
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosette-forming lymphocytes in normals and patients with malignant lymphomas.
    Cohnen G; Augener W; Buka A; Brittinger G
    Acta Haematol; 1974; 51(2):65-75. PubMed ID: 4217078
    [No Abstract]   [Full Text] [Related]  

  • 4. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
    Seligmann M; Preud'Homme JL; Brouet JC
    Transplant Rev; 1973; 16():85-113. PubMed ID: 4204588
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum immunoglobulin E levels in patients with neoplastic disease.
    Waldmann TA; Bull JM; Bruce RM; Broder S; Jost MC; Balestra ST; Suer ME
    J Immunol; 1974 Jul; 113(1):379-86. PubMed ID: 4208923
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface IgD in immunoproliferative disorders.
    Preud'homme JL; Brouet JC; Clauvel JP; Seligmann M
    Scand J Immunol; 1974; 3(6):853-8. PubMed ID: 4218365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I; Diumenjo M
    Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E
    Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
    [No Abstract]   [Full Text] [Related]  

  • 9. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
    Ezdinli EZ; Nanus DM
    Hematol Oncol; 1983; 1(4):297-319. PubMed ID: 6429025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T lymphocyte subpopulations in human peripheral blood.
    Haegert DG; Hallberg T; Coombs RR
    Int Arch Allergy Appl Immunol; 1974; 46(4):525-38. PubMed ID: 4206591
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases.
    Preud'Homme JL; Brouet JC; Seligmann M
    Immunol Rev; 1977; 37():127-51. PubMed ID: 412774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunoglobulin E in patients with chronic lymphocytic leukaemia, multiple myeloma and morbus Waldenström (author's transl)].
    Schwarz S; Gabl F; Pastner D; Huber H; Braunsteiner H
    Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):196-207. PubMed ID: 4283033
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia.
    Hsu CC; Marti GE; Schrek R; Williams RC
    Clin Immunol Immunopathol; 1975 Jan; 3(3):385-95. PubMed ID: 803233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S; Good RA
    Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig.
    Froland SS; Natvig JB; Stavem P
    Scand J Immunol; 1972; 1(4):351-60. PubMed ID: 4590280
    [No Abstract]   [Full Text] [Related]  

  • 16. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis.
    Knapp W; Schuit HR; Bolhuis RL; Hijmans W
    Clin Exp Immunol; 1974 Apr; 16(4):541-52. PubMed ID: 4219765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined T and B lymphocyte marker test in lymphoproliferative disorders.
    Chapel HM; Ling NR
    Br J Haematol; 1977 Mar; 35(3):367-71. PubMed ID: 403927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte membrane markers in acute lymphoblastic leukaemia.
    Aiuti F; Papa G; Lacava V; Ciarla MV; D'Amelio R; Garofalo J
    Br J Haematol; 1974 Aug; 27(4):635-41. PubMed ID: 4547490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.